Randal W. Scott, Director at BridgeBio Pharma, Inc. (BBIO), sold 2,500 shares at $34.00 ($85K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Scheduled sale ($85k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BBIO | SELL | 2025-11-19 | $1.3M | — | Filing → |
| BBIO | SELL | 2024-06-05 | $76K | — | Filing → |
| BBIO | SELL | 2023-12-20 | $80K | — | Filing → |